Moreover, in patients with ischemic stroke associated with proximal intracranial arterial occlusion treated with recombinant tissue plasminogen activator (r-tPA), adjuvant argatroban use resulted in excellent outcomes at 90 days and was not associated with an increased risk of symptomatic intracerebral hemorrhage (ICH) [12]. This evidence concerns the gene PLAT and ischemic stroke.